Home

betale utstilling Ring tilbake teva pharma news israel modernisering jeans utbytte

Netanyahu adviser: Teva could leave Israel if gov't interferes in its  business | The Times of Israel
Netanyahu adviser: Teva could leave Israel if gov't interferes in its business | The Times of Israel

Teva Pharma plans to cut about 5,000 employees
Teva Pharma plans to cut about 5,000 employees

Opioid Manufacturer Teva Pharmaceuticals Reaches $4B Global Settlement |  Law.com
Opioid Manufacturer Teva Pharmaceuticals Reaches $4B Global Settlement | Law.com

Battered by a Tough Generics Market, Teva Pharma Emphasizes Biologics |  BioSpace
Battered by a Tough Generics Market, Teva Pharma Emphasizes Biologics | BioSpace

Teva Pharmaceuticals: Israeli drugmaker to cut 14,000 jobs - BBC News
Teva Pharmaceuticals: Israeli drugmaker to cut 14,000 jobs - BBC News

Teva bought the pharm, and now it may have bought the farm | The Times of  Israel
Teva bought the pharm, and now it may have bought the farm | The Times of Israel

Teva Pharmaceuticals Lays Off Half Its Israeli Workers
Teva Pharmaceuticals Lays Off Half Its Israeli Workers

Former Teva officials said to return $50m over fines paid by drugmaker |  The Times of Israel
Former Teva officials said to return $50m over fines paid by drugmaker | The Times of Israel

Israel's Teva donating potential COVID-19 treatment to US hospitals -  ISRAEL21c
Israel's Teva donating potential COVID-19 treatment to US hospitals - ISRAEL21c

Teva Reaches Tentative $4.25 Billion Settlement Over Opioids - The New York  Times
Teva Reaches Tentative $4.25 Billion Settlement Over Opioids - The New York Times

Teva Pharmaceuticals to pay New York $523 million to settle claims from its  role in opioids crisis - ABC News
Teva Pharmaceuticals to pay New York $523 million to settle claims from its role in opioids crisis - ABC News

New York jury holds drug firm Teva liable in opioid crisis
New York jury holds drug firm Teva liable in opioid crisis

Teva Pharmaceuticals found to be responsible for its role in the opioid  epidemic in New York State | CNN
Teva Pharmaceuticals found to be responsible for its role in the opioid epidemic in New York State | CNN

Teva Israel enters medical cannabis market with new partnership | Reuters
Teva Israel enters medical cannabis market with new partnership | Reuters

FDA Requests More Data on Potential New Treatment for Huntington Disease
FDA Requests More Data on Potential New Treatment for Huntington Disease

Teva Pharmaceuticals (@TevaUSA) / Twitter
Teva Pharmaceuticals (@TevaUSA) / Twitter

Teva Pharmaceuticals found liable in New York opioid trial - BBC News
Teva Pharmaceuticals found liable in New York opioid trial - BBC News

Teva eyes Asian expansion - Pharmaceutical Technology
Teva eyes Asian expansion - Pharmaceutical Technology

teva News and latest stories | The Jerusalem Post
teva News and latest stories | The Jerusalem Post

Israel's Teva Pharm to start paying US opioid settlement in 2023 -CEO - The  Jerusalem Post
Israel's Teva Pharm to start paying US opioid settlement in 2023 -CEO - The Jerusalem Post

Teva looks to amp up research collaborations, CEO says
Teva looks to amp up research collaborations, CEO says

Teva Pharmaceutical set for major layoffs in Israel, US: Report, Health News,  ET HealthWorld
Teva Pharmaceutical set for major layoffs in Israel, US: Report, Health News, ET HealthWorld

Teva to pay NIS 75 million to Israel authorities to settle foreign bribe  claims | The Times of Israel
Teva to pay NIS 75 million to Israel authorities to settle foreign bribe claims | The Times of Israel

Fresh woes emerge as Teva plunges to new lows - Globes
Fresh woes emerge as Teva plunges to new lows - Globes

Teva Pharmaceutical in $4.35 opioid settlement with states, Native American  tribes (TEVA) | Seeking Alpha
Teva Pharmaceutical in $4.35 opioid settlement with states, Native American tribes (TEVA) | Seeking Alpha

A Drug Company Wagers the U.S. Won't Dare Charge It With Crimes - The New  York Times
A Drug Company Wagers the U.S. Won't Dare Charge It With Crimes - The New York Times